We are here to help during COVID-19. We have video appointments available now. If you are a new patient, click here to register.
Insurance accepted and some health plans are waiving copay fees during this time.

We use the first non-invasive, FDA-cleared therapy for OCD in over a decade.

“Obsessions and compulsions can greatly interfere with your daily life and can often be difficult to treat. Behavioral therapies like Cognitive Behavioral Therapy (CBT) and Acceptance-Commitment Therapy (ACT) that include Exposure Response Prevention (ERP) aka “Exposure Therapy,” often combined with serotonin-reuptake inhibitor medications, are still the gold standard of treatment and can work quite well for many patients. However, many people try these therapies and/or medications and cannot tolerate the side effects at doses high enough to find benefit or find that even though they benefit, they still have significant symptoms remaining that get in the way of living life fully.

Transcranial Magnetic Stimulation (TMS) is a non-invasive, outpatient treatment which targets the parts of the brain known to be involved in Obsessive-Compulsive Disorder (OCD) as well as Major Depression. It was approved by the FDA in 2008 to treat Major Depressive Disorder (MDD), and in 2018, BrainsWay Deep Transcranial Magnetic Stimulation (dTMS) was cleared by the FDA for treatment of OCD using a different target and protocol than typically used for depression. This is the first non-invasive medical therapy for OCD in over a decade. The BrainsWay trial and others demonstrated that TMS can be effective at reducing OCD symptoms in treatment-resistant cases and may increase the effectiveness of other treatments like exposure therapy and medications.

Our OCD Program has already helped many patients realize relief from their depression and OCD with TMS therapy, increasing their ability to live the quality of life that they deserve.”

–Ryan Vidrine, MD
Director of OCD Program, TMS Health Solutions